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1Addressing the HIV/AIDS Epidemic at Home and Abroad:  Short Term Policy Options
his past summer, the United States government’s global HIV/AIDS program was reauthorized1 and the 
U.S. Centers for Disease Control and Prevention (CDC) released new data indicating that the epidemic at 
home was worse than previously thought.2  These events called significant attention to HIV/AIDS and 
together present the new Administration and Congress with a unique opportunity to address the epidemic at 
home and abroad.  Several short-term HIV-specific policy options have already been proposed for 
consideration, or are under consideration, by the new Administration and Congress.  This brief provides an 
overview of some of these options, as put forward by non-governmental organizations (NGOs),* and by 
President Obama.  It is not, however, meant to be inclusive of all proposed options nor does it address any 
broader, non HIV-specific policy changes that are also underway – namely, national health care reform and 
foreign aid reform – although such efforts will undoubtedly have significant implications for the government’s 
response to HIV.  
The sources reviewed for this document are listed below. They are followed by a table which arrays each of the 
main options identified for short-term policy attention and indicates whether the option would necessitate an 
administrative and/or legislative action.  A more detailed discussion of options is also provided. 
MAIN SOURCES REVIEWED FOR THIS SUMMARY INCLUDE: 
1. Obama Campaign & Transition Documents:  
a. Barack Obama and Joe Biden’s Plan To Combat Global HIV/AIDS : 
www.barackobama.com/pdf/issues/FactSheetAIDS.pdf ;
b. The Obama-Biden Plan to Combat Global HIV/AIDS:
http://change.gov/pages/the_obama_biden_plan_to_combat_global_hiv_aids/
2. AIDS in America: www.theaidsinstitute.org/downloads/AIDSinAmericaFinal.pdf
Put forth by a coalition of approximately 100 organizations 
3. National AIDS Strategy: www.nationalaidsstrategy.org/
Put forth by a coalition of approximately 350 organizations and 1,200 individuals 
4. Global Health Council’s Global AIDS Roundtable Recommendations (GHC/GAR):  
www.globalhealth.org/images/pdf/2009_transition/gar_document.pdf
Put forth by a coalition or more than 100 U.S.-based and international organizations 
* For purposes of developing this document, in addition to official documents released by the Obama Campaign and 
Transition, only proposals provided by the main, large coalitions of NGOs were reviewed.  It is important to note, however, 
that many of the organizations that signed onto these proposals as well as other organizations have also developed their 
own, individual organizational proposals and options papers. 
T
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PART I: ADRESSING THE DOMESTIC EPIDEMIC 
Below are the short-term options that have been identified by President Obama and/or the major coalitions of 
NGOs.  They are designed to strengthen the response to the domestic epidemic with an emphasis on strategy 
and coordination, increased investment, and a focus on some of the main challenges that remain, particularly 
the difficulty of bringing HIV incidence down, the need to increase the number of people who know their HIV 
status and are receiving services, and the disproportionate impact of HIV on some populations. 
1. Establish National HIV/AIDS Strategy, Leadership, and Centralized Coordination of Domestic 
HIV/AIDS Response. 
Issue: New data released by the CDC signal that the domestic HIV/AIDS epidemic is far from over, and is worse 
than previously thought.  It is now believed that more than 56,000 people are newly infected with HIV each year 
in the U.S., 40% higher than the previous estimate, and a level that has remained unchanged for more than a 
decade.2  In addition, of the more than one million people living with HIV in the U.S., many do not have access 
to care and services,4 including one in five who do not know they are infected.5  Finally, certain populations bear 
the brunt of the epidemic’s impact, particularly Black Americans and gay and bisexual men of all 
races/ethnicities.  The federal government’s response, which began in the 1980s, includes ten federal agencies 
and numerous programs and funding streams.  However, there is no federal mechanism or strategy for 
coordinating across all these programs and funding.  As a result, and given the new data, two large coalitions of 
national AIDS organizations have called for the development of a national HIV/AIDS strategy with funding and 
coordinating authority,6 the 110th Congress passed a concurrent resolution calling for a strategy7 and a similar 
resolution has just been introduced in the House in the new Congress,8 and President Obama stated his 
intention to develop a national strategy.  The NGO coalitions have noted that such a plan is recommended by 
the United Nations Declaration of Commitment9 and Three Ones Principles10, both of which have been signed 
onto by the United States.  It is also central to the U.S. government’s global AIDS response, which revolves 
around one centralized office, coordinator, global and country plans, and authority over all federal funding and 
programs across agencies, an approach which has been credited with success.   
Option: Create First National HIV/AIDS Strategy.  The new Administration is expected to take steps 
to begin development of a national HIV/AIDS strategy. While such a strategy will take time to develop, 
the Administration could announce a timeline, broad goals, funding plan, and process for short and 
long-term strategy development and planning could begin immediately.  In doing so, there are questions 
that will need to be addressed including: whether a new national office and new position of national 
HIV/AIDS coordinator, with authority to oversee the strategy and coordinate across all domestic HIV 
programs and funding streams, will be created [as distinct from the existing Office of National AIDS 
Policy (ONAP) and its Director, created in the late 1990s to coordinate domestic HIV activities but only 
given authority to develop policy guidance; rather, it has been recommended that they be modeled after 
the U.S. global AIDS response, which includes a Global AIDS Coordinator and Office, its own funding, 
and authority over the entire funding and program portfolio].  If such an office and position are created, 
the Administration will have to decide on where they should be located (e.g., in the White House or at a 
department, such as the Department of Health and Human Services); who the coordinator will be; the 
nature of the funding authorities that would be desirable for the coordinator to have and funding levels 
for the new office itself; the roles and responsibilities of each federal agency vis a vis a new centralized 
office, taking into account their current HIV/AIDS portfolios; and the roles and responsibilities of non-
federal partners, particularly state and local jurisdictions, which receive the bulk of federal funding for 
HIV/AIDS and are largely responsible for designing and implementing programs and services.  It is likely 
that new Congressionally-mandated authorities are needed to take some of these steps, and the 
Administration could begin working with Congress to identify and include them in legislative language. 
2. Increase Investment in HIV Prevention, Particularly at State and Local Level 
Issue: As reported by CDC, the new HIV incidence estimates, and confirmation of the epidemic’s 
disproportionate impact on certain populations, provide a “wake-up call” to the U.S. on HIV prevention, and have 
led to a renewed focus on the need to augment domestic HIV prevention efforts.  Yet numerous barriers to 
doing so remain.  For example, despite national recommendations issued by the CDC in 2006 calling for routine 
HIV screening in health care settings for all adults and adolescents, significant shares of people with HIV do not 
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know they are infected and many are diagnosed late in their illness.  In addition, national HIV prevention goals 
have not been met in part because HIV prevention has not been funded or implemented at the level needed to 
make a further impact11,12,13 – since FY 2002, for example, federal funding for HIV prevention at CDC has 
decreased by 4 percent.14  It was $753.6 million in FY 2008 (only 4% of the federal AIDS budget), and no 
increase was requested for FY 2009.  Furthermore, many state and local jurisdictions, which rely heavily on 
federal prevention funding, already face economic hardship and in a recent survey cited funding shortages as 
the top challenge confronting their HIV prevention response.15  These trends prompted the House Committee on 
Oversight and Government Reform to convene a hearing on domestic HIV prevention and to request that CDC 
provide an estimate of the funding that would be needed (a professional judgment budget) to fully implement 
effective HIV prevention in the United States.16  According to CDC, in order to prevent thousands of new HIV 
infections and reduce HIV-related disparities, an additional $877 million would be needed in FY 2009, and 
$4,784 million over 5 years.13  Some of the options identified that the new Administration and Congress could 
undertake to signal a high-level national commitment to HIV prevention and/or provide immediate fiscal relief 
include: 
Option: Increase Funding for HIV Prevention.  As part of its first budget request, for FY 2010, which 
is expected to be released in the spring of 2009, the Administration could include the additional funding 
requested for HIV prevention in the CDC’s professional judgment budget.  It could also announce the 
importance of elevating the HIV prevention response early on, calling attention to the continued 
epidemic in the United States and noting that HIV prevention will be a prominent part of the national 
HIV/AIDS strategy.  The Congress could also take short-term steps by appropriating the additional funds 
requested in the CDC’s professional judgment budget for FY 2009.   
Option: Promote Routine HIV Screening Through Medicaid and Medicare 
Despite public health service recommendations calling for routine (population-based) HIV screening, 
there continue to be barriers to funding and implementing them, including by other federal programs, 
particularly Medicaid and Medicare.  While routine screening is technically a reimbursable service under 
Medicaid, the nation’s federal-state health insurance program for low-income individuals which reaches 
significant shares of those living with and at risk for HIV, it is considered an optional benefit, meaning 
that states have to choose to cover it if they want to receive federal matching funds.  To date, no 
guidance has been provided by the federal government to the states on the new public health service 
recommendations, the importance of routine screening for the Medicaid population, and the ability of 
states to cover routine screening as an optional benefit and receive federal matching funds for its 
provision.  The Centers for Medicare and Medicaid Services (CMS), the federal agency which 
administers Medicaid, could inform all states about routine screening and encourage them to cover it in 
their state Medicaid plans.  A further avenue that can be used to promote routine screening is Medicare, 
the federal health insurance program for the elderly and disabled.  Medicare also reaches people at risk 
for HIV (particularly the under-65 disabled) but, while HIV testing of individuals in the context of a 
medical care visit is a covered service under Medicare (if recommended by a provider), routine HIV 
screening is not.  Congressional legislation would be needed to make such a change in Medicare.     
Option: Remove Ban on Use of Federal Funds for Needle/Syringe Exchange (NSEPs) 
Injection drug use (IDU) continues to contribute to HIV transmission in the United States, although 
prevention efforts have been successful at driving down its impact over time.2,17  Still, injection drug use 
directly accounts for more than a quarter of HIV transmissions which have occurred since the beginning 
of the epidemic, and a greater share indirectly, through transmission to the sexual partners and children 
of IDUs.18  To help reduce IDU-related HIV transmission, a comprehensive prevention approach is 
recommended, including the use of sterile needles and syringes.  As CDC states: “for injection drug 
users who cannot or will not stop injecting drugs, using sterile needles and syringes only once remains 
the safest, most effective approach for limiting HIV transmission.”19  Needle and syringe exchange 
programs (NSEPs), however, have been controversial in the United States and U.S. law has prohibited 
the use of federal funding for this purpose since 1988.  To date, therefore, NSEPs have had to rely on 
funding from state and local governments and private organizations only.  At the same time, there have 
been numerous scientific studies, including by the CDC, the U.S. Government Accountability Office 
(GAO), Institute of Medicine (IOM), and others, showing that NSEPs, offered as part of a 
comprehensive prevention strategy, are associated with a decrease in drug-related HIV risk behavior 
and do not lead to increased drug use, crime, or discarded needles/syringes.20  As a result, many 
groups have issued recommendations to remove the federal funding ban on NSEPs and President 
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Obama indicated his intention to do so during his campaign.  Because the ban is codified in U.S. law, 
however, any change would need to be made legislatively by Congress.  A bill to eliminate the ban, The
Community AIDS and Hepatitis Prevention Act (H. R. 179), was recently introduced in the 111th
Congress.21
3. Increase Access to Care and Treatment for People with HIV/AIDS 
Issue:  Despite great strides in HIV care and treatment, including the introduction of highly active antiretroviral 
therapy in 1996 which has led to a dramatic reduction in HIV-related deaths and extended the lives of thousands 
of people with HIV22,23, many still face barriers to accessing programs and services.  For example, a recent 
analysis found that only 55 percent of those who met the clinical criteria for antiretroviral therapy were receiving 
it.4  Among the many challenges they face are program eligibility restrictions, capacity limitations, and variation 
in the availability of services across the country.  For example, eligibility rules for Medicaid, the major source of 
coverage for people with HIV in the U.S., present a “Catch-22” relative to the current standard of HIV care in that 
many low-income people with HIV are not eligible for Medicaid until they become disabled, despite available 
therapies through Medicaid that may prevent disability.  The Ryan White Program, the nation’s single largest 
federal program designed specifically for people with HIV/AIDS who have no or limited insurance coverage, and 
which includes the AIDS Drug Assistance Program (ADAP), has faced funding shortages for several years, 
resulting in ADAP waiting lists and other program limitations.24  There are several short-term administrative and 
legislative options that have been identified to lessen or even eliminate some of these barriers and enhance 
access including: 
Option: Include Antiretrovirals as Protected Drug Class under Medicare Part D.  The basic 
formulary standard in Medicare Part D, the prescription drug program of Medicare, requires plans to 
cover at least two drugs per drug class.  Since the Part D program started, annual guidance has been 
issued by CMS requiring plans to cover “all or substantially all” drugs in six key classes, including 
antiretrovirals.  Congress recently sought to codify this policy (under P.L. 110-275) by establishing a 
process for the Secretary to designate drug classes for special protection.  Just this month, CMS 
announced an interim final rule that would extend such protection through 2010, but the rule has not yet 
gone into effect.25  This rule could be finalized and protection ensured for beneficiaries with HIV and 
other groups, who benefit from such protections.   
Option: Permit ADAP Spending to Count Toward TrOOP under Medicare Part D.  When Congress 
established the Medicare Part D program, drug spending by other government programs was prohibited 
from counting toward true out-of-pocket costs (TrOOP), costs that accrue during the coverage gap or 
“doughnut hole” of Part D, during which coverage is not available until a catastrophic ceiling has been 
reached.  Congress exempted State Pharmacy Assistance Programs (SPAPs) from this requirement but 
the Administration interpreted the law such that ADAPs are not considered SPAPs.  Therefore, any 
ADAP funding used for Medicare eligible people with HIV is not counted toward TrOOP, potentially 
leading to a situation where an individual can never reach the catastrophic coverage level and will 
continue to need to rely on limited ADAP funds.  The Administration could reinterpret its rules and 
determine that ADAPs qualify as SPAPs, which would loosen up pressure on ADAP funds. 
Option: Enact the Early Treatment for HIV Act (ETHA) to Enhance Access to Medicaid.  To change 
Medicaid eligibility to cover low income individuals with HIV who are not disabled or otherwise 
categorically eligible, would require Congressional legislation.  Congress has introduced such 
legislation, allowing for a state Medicaid option to provide Medicaid coverage to low income people with 
HIV prior to disability and receive an enhanced federal Medicaid match, for the past several years.  The 
legislation has not passed Congress.  Congress could enact legislation thereby expanding eligibility in 
those states that choose to use the option.   
Option: Extend Reauthorization of the Ryan White HIV/AIDS Treatment Modernization Act and 
Increase its Funding 
The Ryan White Program, first created in 1990, was reauthorized for the third time in 2006.  Unlike prior 
authorizations of the program, which each spanned a five-year period, the most recent reauthorization 
was for a three-year period and includes a sunset provision ending the authorization on September 30, 
2009.26  This shorter time frame was chosen by Congress to allow for the bill to be reauthorized in 2006 
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despite the existence of several outstanding and complicated issues.  However, many believe not 
enough time has gone by to fully implement the last reauthorization, which would prevent some critical 
decisions from being reached.  As such, Congress could extend the current Act through a later period, 
and ensure continuity in the program, while some of the other issues are being addressed.  In addition, 
funding for the program, other than ADAP, has remained relatively flat for several years; while ADAP 
has received some increases, it continues to struggle with waiting lists and other limitations.  The 
current economic downturn is likely to further pressure on programs like Ryan White.  Congress could 
appropriate additional funding for FY 2009 for Ryan White, and the President could request funding over 
this amount for FY 2010. 
PART II: THE GLOBAL EPIDEMIC 
The last several years have seen the creation of a major new U.S. global AIDS initiative, including a significant 
increase in funding, which has been cited as a bipartisan success with U.S. leadership helping to lead to a 
stepped-up response throughout the world.  Looking forward, it will be important for the U.S. to continue its 
existing effort, build upon its successes, and improve its response where needed and given changes in the 
epidemic and country needs over time.  Possible short-term options that have been identified include: 
1. Address Outstanding Barriers to Implementation of a Comprehensive Response to the 
Global Epidemic
Issue.  The creation of the President’s Emergency Plan for AIDS Relief (PEPFAR) in 2003, with strong support 
by the President and Congress, marked a historic move forward in the global response to the epidemic, and has 
been cited as a prime example of bipartisan cooperation.  Over the first five years of the program, PEPFAR 
supported antiretroviral treatment for more than 2 million people, prevention of more than 7 million infections, 
and care for more than 10 million.27  In addition to successes, the first five-years of PEPFAR provided many 
lessons learned and the recent reauthorization of the program, now called The Tom Lantos and Henry J. Hyde 
United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, 
addressed several of these issues, including for example, increasing annual authorization levels, relaxing some 
earmarks on HIV funding generally and for prevention specifically, and ending a statutory prohibition against 
HIV-positive visitors and immigrants.  Still, President Obama and NGO coalitions have identified several 
outstanding issues that could benefit from additional policy guidance and clarification, or through new legislative 
language.   
Already, one of the issues that had been identified – that of rescinding the Mexico City Policy, or so-called 
Global Gag Rule – was acted upon by the President during his first week in office.  The Mexico City Policy had 
prohibited the provision of federal funding to any NGO that performed or promoted abortion, even if such 
activities were funded through separate sources.  First initiated by President Reagan in 1984, the policy was 
rescinded by President Clinton in 1993, and re-instated by President Bush in 2001.  In 2003, President Bush 
issued a memorandum exempting PEPFAR funding from this restriction.  The Mexico City Policy has been 
controversial throughout its history, with many organizations that provide services to women at risk for and living 
with HIV indicating that the rule, even with the PEPFAR exemption, was at best ambiguous and at worst had 
discouraged or even prevented some organizations from being able to reach populations in need.  On Friday, 
January 23, 2009, President Obama issued a memorandum rescinding the policy.3
Additional issues that have been identified include the following:  
Option: Clarify “Anti-Prostitution Pledge” Requirement.  The first authorization of PEPFAR included 
language forbidding the receipt of funding organizations unless they had an explicit policy in place 
opposing prostitution and sex trafficking; the reauthorization maintained the language.  The 2003 
language was initially interpreted by the Administration to apply only to foreign NGOs, but extended to 
U.S.-based NGOs in 2005.  The policy as applied to U.S.-based NGOs was challenged in court, 
including a challenge to federal guidance that sought to clarify that private funds could be used freely 
without a pledge requirement if an organization set up a separate entity for this purpose. A recent 
federal court ruling found the requirement to be a violation of the First Amendment, a decision which 
has since been appealed by the government.  This court decision, coupled with an ongoing concern that 
the provision has prevented some organizations from reaching all those in need of services, has led to 
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some calling for the Administration and Congress to address the issue in the short run.  This could be 
done by the Administration through a reinterpretation of policy to exempt U.S.-based NGOs from the 
requirement (although the provision would still apply to foreign NGOs).  Congress could pass legislation 
removing all or part of the requirement.  
Option: Clarify Reauthorization Language on the Need for “Balanced Funding” for HIV  
Prevention.  One of the challenging issues that arose during the first five-years of PEPFAR was the 
earmark on HIV prevention funding, requiring that 33 percent of PEPFAR funds appropriated for 
prevention be spent on abstinence-until-marriage programs.  The General Accounting Office, the 
Institute of Medicine and other organizations recommended the removal of this requirement after finding 
that it limited program reach on the ground.28,29  The recent reauthorization removed the earmark and 
relaxed the condition, substituting instead a requirement for “balanced funding” for prevention, including 
a report to Congress if less than half of prevention funds in any host country were provided to 
“abstinence, delay of sexual debut, monogamy, fidelity, and partner reduction”.  Existing policy guidance 
does not yet reflect this new language and there continues to be confusion about the interpretation of 
the new language.  The Administration could issue guidance updating the language and indicating that 
the earmark has been removed, as well as providing parameters on what kind of report would be 
required if needed. 
Option: Change Policy to Permit Use of Federal Funds for Syringe/Needle Exchange in Global 
AIDS Programs 
Globally, there are an estimated 13.2 million injecting drug users, most of whom (78 percent) live in 
developing and transitional countries.  According to UNAIDS, injecting drug use accounts for at least 10 
percent of all new HIV infections globally, rising to nearly one-third of new infections outside of sub-
Saharan Africa.  In some regions and countries, injecting drug use is the main driver of the HIV 
epidemic.30  The current legislative ban on the use of federal funding for NSEPs, first instituted in 1988, 
only applies to funding provided through the Department of Health and Human Services and no similar 
legislative ban exists for other funding streams.  However, since 2002, the U.S. Agency for International 
Development (USAID) has promulgated policy prohibiting the use its funds for NSEPs31,32 and the Office 
of the U.S. Global AIDS Coordinator at the State Department has issued such guidance as applied 
specifically to global AIDS funding.33  While U.S. funding for global HIV/AIDS activities provided by the 
State Department and USAID can be coordinated with NSEP activities supported by other donors, U.S. 
funds must be segregated, coded separately, and thoroughly monitored to ensure that they are not 
being used for needles and syringes.  As noted above, numerous scientific studies have determined 
that NSEPs, offered as part of a comprehensive prevention strategy, are associated with a decrease in 
drug-related HIV risk behavior and do not lead to increased drug use, crime, or discarded 
needles/syringes.20  Therefore many organizations, including the Institute of Medicine in a recent report, 
have issued recommendations to change this policy as it applies to U.S. global AIDS funding and 
President Obama has indicated his intention to remove restrictions on such funding during his 
campaign.  Such a change could be made through new policy guidance issued by the State Department 
and USAID and would not require legislative action. 
Option: Clarify the Need to Ensure the Continuity and Timeliness of Services if Conscience 
Clause/Right of Refusal is Invoked 
The initial global AIDS authorization in 2003 included language permitting organizations eligible to 
receive global AIDS funding to opt out of providing a prevention or treatment service on religious or 
moral grounds, often referred to as the “refusal” or “conscience” clause.  The 2008 reauthorization 
reaffirmed and extended the conscious clause language beyond prevention and treatment to apply to 
“care”.  Concerns have been raised that this could result in individuals not getting services they need or 
facing lapses in service delivery.  The IOM, in its Congressionally-mandated report on PEPFAR, raised 
this concern and underscored the importance of ensuring routine and consistent referrals where 
needed.28  While changing or removing this language would require Congressional legislation, the 
Administration could issue guidance to the field about the necessity of ensuring the continuity and 
timeliness of the provision of high quality prevention, treatment, and care services to all clients whether 
or not an organization refused to provide a particular service directly. 
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2.  Continue U.S. Commitment to People with HIV on Antiretroviral Treatment and Scale-up 
Prevention
Issue. One of the reasons the Congress and Administration moved to reauthorize the global AIDS program this 
past summer was to help send a message to recipient nations that the U.S. commitment would continue, and to 
authorize increased funding levels for the program in recognition of the growing costs of keeping people on 
antiretrovirals, reaching more people with treatment, and need to greatly scale up HIV prevention services.  The 
reauthorization raised funding levels from $15 billion over the first five-year period to $48 billion for the next five-
year period.  However, since that time, the global financial crisis has called all large-scale programs into 
question and new concern about the continuation of the U.S. commitment has been raised.  While all recognize 
that the economic crisis has changed the stakes, there is also a need to keep people on antiretroviral treatment 
and further address the epidemic. 
Option: Continue Global AIDS Funding. The Congress is still finalizing FY 2009 appropriations and 
could include a minimal increase over FY 2008 funding levels of almost $6 billion, as already requested 
by President Bush.  The new Administration could include an additional increase in its request for FY 
2010 funding.  Both of these steps would ensure continuation of existing programs, including meeting 
growing program costs, while leaving additional scale up to later years. 
3.  Finalize Policy Change Ending HIV Travel and Immigration Ban 
Issue: The recent reauthorization of PEPFAR removed a statutory ban that had been in place since 1993 and 
which prohibited people with HIV from traveling or immigrating to the United States.34  The removal of the 
legislative ban returned the decision about which such health conditions were grounds for exclusion to the 
Department of Health and Human Services, which maintains the list of inadmissible conditions of public health 
significance.  To date, the Department has not removed HIV from the list although it has indicated that it is 
working to do so.       
Option:  Expedite Removal of HIV from the Government’s List of Excludable Health Conditions.
The Administration could expedite the removal of the ban by immediately having the Department of 
Health and Human Services remove HIV from the list of inadmissible conditions of public health 
significance.  Once HIV has been removed from the list, the Administration could issue new guidance to 
all immigration and naturalization officers and offices to ensure as smooth a transition as possible.
CONCLUSION 
While the new Administration and Congress will face daunting challenges and economic pressures, the U.S. 
government’s response to HIV/AIDS remains critical.  On the global front, the U.S. program has been cited as a 
bipartisan success, with U.S. leadership helping to result in a larger global response – continuing that effort and 
allowing it appropriate flexibility could be pursued in the short-term and send important signals, particularly to 
those countries and people who depend on U.S. government support.  Domestically, a variety of options have 
been proposed that could be pursued in the short-term by the new Administration and Congress and which 
could help to provide an immediate impact and/or signal an ongoing commitment.  In both cases, short-term 
responses can also help to lay the groundwork for how HIV/AIDS fits into broader national health reform and 
foreign aid reform efforts. 
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